August 22, 2024 Neuralink’s Second Patient Is Already Playing Counter-Strike 2 “Alex” is using the brain-computer interface to shoot people in a video game and design improvements to his setup in Fusion 360.
August 22, 2024 Ring’s new pan-and-tilt security camera drops to $60 in its first discount Home security devices can give us peace of mind, but they don’t always come cheaply. That’s why we’re excited to see Ring’s Pan-Tilt Indoor…
August 22, 2024 Instagram copies…Myspace? If there’s one thing that’s guaranteed in the world of social media, it’s that platforms are going to copy each other’s features. However, the…
August 22, 2024 Empowering the AI-enabled workforce with data With its capabilities for code and content creation, and tools like Copilot already transforming the way people work, generative AI is helping organizations to…
August 22, 2024 GitHub Enterprise Server has a critical security flaw, so patch now GitHub Enterprise Server, the self-hosted version of the GitHub platform, was found carrying a vulnerability that allowed malicious actors to elevate their privileges to…
August 22, 2024 Here’s the Latest Timeline on a Rumored Foldable MacBook The mammoth 18.8-inch folding MacBook (or perhaps iPad) won’t arrive until 2027 at the earliest, according to the latest Apple rumormongers.
August 22, 2024 Google Pixel 9 review: The go-to Android smartphone For the first half of Android’s existence, Google was happy simply being in charge of the OS while other manufacturers built a massive ecosystem…
August 22, 2024 Ford slams the brakes on its pure EV plans – and is taking the hybrid road instead Ford is the latest major automotive player to scale back ambitious plans for future electric vehicles, stating that it has scrapped an all-electric, seven-seat SUV…
August 22, 2024 Updates From The Batman Part II, and More Plus, get one last look at Evil as it prepares for today’s season finale.
August 22, 2024 Neuralink says it may have fixed its brain implant problem Neuralink has published an update on the second patient in its early human trials, and it said that “promisingly,” it has “observed no thread…